Oruka Therapeutics, Inc.
ORKA$372M
Small CapNASDAQPharmaceutical Preparations🇺🇸North AmericaMENLO PARK28 employees
Drugs in Pipeline
3
Phase 3 Programs
0
Upcoming Catalysts
3
Next Catalyst
Aug 10, 2026
7wMarket Overview
Stock performance and key metrics
ORKA News
Catalyst Timeline
3 upcoming, 0 past
Drug Pipeline
ORKA-001 Induction Dose
Plaque Psoriasis
ORKA-001
Plaque Psoriasis
ORKA-002
Plaque Psoriasis
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
ORKA-001 Induction Dose | Phase 2 | Plaque Psoriasis | - | - |
ORKA-001 | Phase 2 | Plaque Psoriasis | - | - |
ORKA-002 | Phase 2 | Plaque Psoriasis | - | - |
Catalyst Verdict
Market-Implied Move
Regulatory Approvals
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply